BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7962217)

  • 1. National Cancer Institute Drug Information System 3D database.
    Milne GW; Nicklaus MC; Driscoll JS; Wang S; Zaharevitz D
    J Chem Inf Comput Sci; 1994; 34(5):1219-24. PubMed ID: 7962217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCI Drug Information System. 3. The DIS Chemistry Module.
    Milne GW; Feldman A; Miller JA; Daly GP
    J Chem Inf Comput Sci; 1986 Nov; 26(4):168-79. PubMed ID: 3818817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCI Drug Information System. 4. Inventory and Shipping Modules.
    Milne GW; Miller JA; Hoover JR
    J Chem Inf Comput Sci; 1986 Nov; 26(4):179-85. PubMed ID: 3818818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCI Drug Information System. 2. DIS Pre-Registry.
    Milne GW; Feldman A; Miller JA; Daly GP; Hammel MJ
    J Chem Inf Comput Sci; 1986 Nov; 26(4):159-68. PubMed ID: 3818816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NCI Drug Information System. 1. System overview.
    Milne GW; Miller JA
    J Chem Inf Comput Sci; 1986 Nov; 26(4):154-9. PubMed ID: 3818815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCI Drug Information System. 5. DIS Biology Module.
    Zehnacker MT; Brennan RH; Milne GW; Miller JA
    J Chem Inf Comput Sci; 1986 Nov; 26(4):186-93. PubMed ID: 3818819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies of the Universal Chemical Key (UCK) algorithm on the NCI database of chemical compounds.
    Grossman R; Kasturi P; Hamelberg D; Liu B
    Proc IEEE Comput Soc Bioinform Conf; 2003; 2():244-50. PubMed ID: 16452799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling in the discovery of drug leads.
    Milne GW; Wang S; Nicklaus MC
    J Chem Inf Comput Sci; 1996; 36(4):726-30. PubMed ID: 8768766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCI Drug Information System. 6. System maintenance.
    Zehnacker MT; Brennan RH; Milne GW; Miller JA; Hammel MJ
    J Chem Inf Comput Sci; 1986 Nov; 26(4):193-7. PubMed ID: 3580042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking approach on the Topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database.
    Lauria A; Ippolito M; Almerico AM
    J Mol Model; 2007 Mar; 13(3):393-400. PubMed ID: 17072654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining and visualizing large anticancer drug discovery databases.
    Shi LM; Fan Y; Lee JK; Waltham M; Andrews DT; Scherf U; Paull KD; Weinstein JN
    J Chem Inf Comput Sci; 2000; 40(2):367-79. PubMed ID: 10761142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced CACTVS browser of the Open NCI Database.
    Ihlenfeldt WD; Voigt JH; Bienfait B; Oellien F; Nicklaus MC
    J Chem Inf Comput Sci; 2002; 42(1):46-57. PubMed ID: 11855965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the NCI open database with seven large chemical structural databases.
    Voigt JH; Bienfait B; Wang S; Nicklaus MC
    J Chem Inf Comput Sci; 2001; 41(3):702-12. PubMed ID: 11410049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity.
    Shi LM; Myers TG; Fan Y; O'Connor PM; Paull KD; Friend SH; Weinstein JN
    Mol Pharmacol; 1998 Feb; 53(2):241-51. PubMed ID: 9463482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical data mining of the NCI human tumor cell line database.
    Wang H; Klinginsmith J; Dong X; Lee AC; Guha R; Wu Y; Crippen GM; Wild DJ
    J Chem Inf Model; 2007; 47(6):2063-76. PubMed ID: 17915856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHMIS-C: a comprehensive herbal medicine information system for cancer.
    Fang X; Shao L; Zhang H; Wang S
    J Med Chem; 2005 Mar; 48(5):1481-8. PubMed ID: 15743190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PASS biological activity spectrum predictions in the enhanced open NCI database browser.
    Poroikov VV; Filimonov DA; Ihlenfeldt WD; Gloriozova TA; Lagunin AA; Borodina YV; Stepanchikova AV; Nicklaus MC
    J Chem Inf Comput Sci; 2003; 43(1):228-36. PubMed ID: 12546557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multivariate insight into the in vitro antitumour screen database of the National Cancer Institute: classification of compounds, similarities among cell lines and the influence of molecular targets.
    Musumarra G; Condorelli DF; Costa AS; Fichera M
    J Comput Aided Mol Des; 2001 Mar; 15(3):219-34. PubMed ID: 11289076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DBMAKER: a set of programs to generate three-dimensional databases based upon user-specified criteria.
    Ho CM; Marshall GR
    J Comput Aided Mol Des; 1995 Feb; 9(1):65-86. PubMed ID: 7751871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations in the National Cancer Institute antitumor drug screening database for evaluating hormesis.
    Crump KS
    Toxicol Sci; 2007 Aug; 98(2):599-601; author reply 602-3. PubMed ID: 17535829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.